Trustees of Boston University has been awarded a $68,533 firm fixed price purchase order by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS). Under this contract, Boston University will select participants from the Black Women's Health Study (BWHS) with DNA or blood/buccal specimens amenable to germline DNA extraction. The university will aliquot and ship the DNA specimens to NCI and provide select...
This is a $85,000.00 firm fixed price purchase order awarded by the National Cancer Institute (NCI), a civilian agency within the National Institutes of Health (NIH), to the Trustees of Boston University. The contract is for a research project titled "MRNA EXPRESSION AMONG WORKERS EXPOSED TO DIESEL EXHAUST AND CONTROLS" with a period of performance ending on September 21, 2016. The contract was not set aside for any special designations. As a private university, Boston University has a...
This firm-fixed-price purchase order contract, valued at $90,000.00, was awarded by the National Cancer Institute (NCI) to the Trustees of Boston University, doing business as Boston University Medical Campus, to conduct research examining item-to-item bridge work and sample evolution problems in the SEER-MHOS data resource. The contract has a performance period ending on May 31, 2017 and does not have a set-aside designation. Boston University, a leading private research institution, frequently...
This federal contract award to Trustees of Boston University, doing business as Boston University Medical Campus, is for laboratory and testing services with a ceiling value of $24,980. The contract was awarded by the National Cancer Institute, a civilian agency under the Department of Health and Human Services. The services will be performed in Boston, Massachusetts. The contract does not have a set-aside designation, reflecting Boston University's extensive research capabilities as a leading...
This firm-fixed-price purchase order for $302,039.20 was awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to BostonGene Corporation. The contract is for targeted deep sequencing and bioinformatics analysis of 162 human plasma samples to support a clinical trial investigating the safety and efficacy of the Copanlisib/Rituximab combination treatment for previously untreated follicular lymphoma patients. The objective is to obtain plasma...
The U.S. National Institutes of Health (NIH), National Cancer Institute (NCI) has awarded a $50,000.00 firm fixed-price purchase order to the Regents of the University of California, San Francisco (UCSF) to obtain historical samples of frozen tumor tissue and adjacent normal lung tissue from never-smoking lung cancer patients, along with accompanying medical documentation and data. This purchase order is part of the NCI's Sherlock-Lung study, an international whole-genome sequencing study of...
This is a $52,375 firm fixed-price purchase order contract awarded by the National Heart Lung and Blood Institute, a component of the National Institutes of Health, to the Trustees of Boston University (doing business as Boston University Medical Campus). The contract is for "Mitochondrial Clonal Hematopoiesis of Indeterminate Potential (CHIP) Calling" research and services. The contract does not have a set-aside designation. Boston University is a leading private research...
This is a firm fixed price purchase order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Trustees of Boston University, a private university, to provide analytical support services. The contract has a ceiling value of $79,654.00 and a period of performance ending on March 19, 2018. The contract was awarded on July 27, 2017 and is not set aside for any particular type of business. As a prime contractor, Boston...
This is a Firm Fixed Price Delivery Order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency within the U.S. government, to Trustees of Boston University (doing business as Boston University Medical Campus) for the establishment of a "Biorepository of Lung Disease-Specific Human Induced Pluripotent Stem Cells (BHIPSC-Lung)." The contract has a ceiling value of $644,020.00 and a period of performance through May 1, 2030. The contract is not set...
This is a federal contract award from the National Cancer Institute (NCI), which is part of the National Institutes of Health (NIH), a civilian agency. The contract, valued at $7,053,827.00, was awarded to the University of Maryland, Baltimore (UMB) to serve as a resource for the collection of human tissue, cells, biofluids, and epidemiologic profiles from donors to support NCI's Laboratory of Human Carcinogenesis research programs. The contract has a 1-year base period and four 1-year option...